Action HCIL HONGCHANG INTERNATIONAL CO., LTD
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Hongchang International Co., Ltd

Actions

HCIL

US42831T2024

Marché Fermé - OTC Markets
Autres places de cotation
 16:41:02 26/06/2024 		Varia. 5j. Varia. 1 janv.
0,2001 USD -.--% Graphique intraday de Hongchang International Co., Ltd -.--% -42,63 %
15/05 Hongchang International Co., Ltd présente ses résultats pour le premier trimestre clos le 31 mars 2024 CI
08/05 Hongchang International Co. annonce la démission de Xingjia Gao en tant que membre du conseil d'administration CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !
Inscription 100% Gratuite
Hongchang International Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024
Hongchang International Co., Ltd Announces Resignation of Xingjia Gao as a Director from the Board
Hongchang International Co., Ltd Announces CFO Changes
Hongchang International Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023
Hongchang International Co., Ltd Announces Board Changes
Hongchang International Co., Ltd. has Changed its Ticker to HCIL from HYBT
Heyu Biological Technology Corporation has Changed its Name to Hongchang International Co., Ltd
Hongchang International Co., Ltd Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Hong Chang Biotechnologies (HK) Limited completed the acquisition of Heyu Biological Technology Corporation (OTCPK:HYBT.D) in a reverse merger transaction.
Heyu Biological Technology Corporation Appoints Zengqiang Lin as the Chief Executive Officer
Heyu Biological Technology Corporation Announces Board and Executive Changes
Heyu Biological Technology Corporation Appoints Wendy Wei Li as the Chief Financial Officer of the Company
Hong Chang Biotechnologies (HK) Limited entered into an agreement to acquire Heyu Biological Technology Corporation (OTCPK:HYBT.D) in a reverse merger transaction for HKD 4.4 billion.
Heyu Biological Technology Corporation Reports Earnings Results for the Half Year Ended June 30, 2023
Insider Buy: Heyu Biological Technology
Heyu Biological Technology Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023
HEYU BIOLOGICAL TECHNOLOGY CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
Heyu Biological Technology Corporation Auditor Raises 'Going Concern' Doubt
HEYU BIOLOGICAL TECHNOLOGY : ANNOUNCES APPOINTMENT OF NEW INDEPENDENT DIRECTOR - Form 8-K
HEYU BIOLOGICAL TECHNOLOGY CORP : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action HCIL
  4. Actualités Hongchang International Co., Ltd
  5. Autres langues